EUVIMEDObjevte EUVIMED
LeitlinieOpen access · CC BY-NC-ND 4.0

The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub‐Saharan Africa. A study from the Franco‐African Pediatric Oncology Group

Brenda Mallon iD, Rolande Kaboré, Line Couitchere iD, Fatou Binetou Akonde, Mbolanirina Lala Rakotomahefa Narison, Aléine Budiongo, Tankélé Arsène Dackono, Angel Pondy, Francis Diedhiou, Catherine Patte, Eva Steliarova-Foucher, Jacqueline Clavel

Pediatric Blood & Cancer · 2023-12 · 70 (12)

DOI: 10.1002/pbc.30664 ↗

At a glance

Leitlinie in Pediatric Blood & Cancer, published online on 2023-09-21. Written by Brenda Mallon and 11 co-authors. Institution: Groupe Franco-Africain d'Oncologie Pédiatrique (GFAOP) Gustave Roussy Villejuif, Villejuif, France. Major MEDLINE topics: Neoplasms, Central Nervous System Neoplasms, Brain Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Cited 11 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: World Health Organization.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

The improvement of childhood cancer outcome is determined by early diagnosis, effective treatment, supportive care, and adequate medical follow‐up. Stage at diagnosis may reflect timeliness of diagnosis, therefore standardized registration of stage is essential for interpretation of regional differences and time trends in survival. Here, we describe the feasibility of implementing the Toronto Childhood Cancer Stage Guidelines (hereafter Toronto Guidelines [TG]) in the hospital‐based cancer registry of the Franco‐African Pediatric Oncology Group (GFAOP), and assess the impact of TG stage on outcome in pediatric oncology units (POUs) in seven low‐ and middle‐income countries in sub‐Saharan Africa (SSA).

Methods

All cancer patients diagnosed before 15 years of age with one of the 15 cancer types defined in TG, resident in one of the participating countries, and attending one of the selected POUs in 2017–2019 were included. Stage was assigned according to TG. Patients were followed‐up for vital status for at least 12 months post diagnosis. Survival at 3, 6, and 12 months was calculated using Kaplan–Meier method and compared between POUs and tumor groups using log‐rank test.

Results

TG stage was assigned to 1772 of 2446 (89%) cases diagnosed with one of 11 cancer types. It was not possible to assign TG stage to acute lymphoblastic leukemia (ALL) and the three types of the central nervous system tumors included in the TG. One‐year overall survival (OS) was 58% [95% confidence interval: 55–60] and varied between POUs. Survival declined with increasing stage for four tumor types and was statistically significant for two.

Conclusion

Except for ALL and brain tumors, we demonstrated feasibility of TG implementation for childhood solid cancers in participating POUs in SSA, and provided a baseline assessment of childhood cancer outcomes against which future stage distribution and survival can be measured as timelines of diagnosis improve over time within the GFAOP network.

Subjects

MeSH terms (MEDLINE)

NeoplasmsCentral Nervous System NeoplasmsBrain NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaChildHumansFeasibility StudiesMedical OncologyAfrica South of the Sahara

Author keywords

GFAOPLMICchildhood cancersregistrystagesub-Saharan Africa

Authors and institutions

  • Groupe Franco-Africain d'Oncologie Pédiatrique (GFAOP) Gustave Roussy Villejuif, Villejuif, France.
  • Service d'oncologie pédiatrique, Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso.
  • Unité d'oncologie pédiatrique, Hôpital de Treichville, Abidjan, Ivory Coast.
  • Unité d'oncologie pédiatrique, Hôpital Aristide Le Dantec, Dakar, Senegal.
  • Unité d'oncologie pédiatrique, CHU JRA Antananarivo, Antananarivo, Madagascar.
  • Unité d'oncologie pédiatrique, Cliniques Universitaires de Kinshasa, Kinshasa, Congo.

ORCID profiles: Brenda Mallon, Line Couitchere

Funding

  • World Health Organization

Cite

APA

Mallon, B., Kaboré, R., Couitchere, L., Akonde, F. B., Narison, M. L. R., Budiongo, A., Dackono, T. A., Pondy, A., Diedhiou, F., Patte, C., Steliarova-Foucher, E., & Clavel, J. (2023). The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub‐Saharan Africa. A study from the Franco‐African Pediatric Oncology Group. Pediatric Blood & Cancer, 70(12). https://doi.org/10.1002/pbc.30664

Vancouver

Mallon B, Kaboré R, Couitchere L, Akonde FB, Narison MLR, Budiongo A, et al. The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub‐Saharan Africa. A study from the Franco‐African Pediatric Oncology Group. Pediatric Blood & Cancer. 2023;70(12). doi:10.1002/pbc.30664

BibTeX
@article{Mallon2023,
  author = {Mallon, Brenda and Kaboré, Rolande and Couitchere, Line and Akonde, Fatou Binetou and Narison, Mbolanirina Lala Rakotomahefa and Budiongo, Aléine and Dackono, Tankélé Arsène and Pondy, Angel and Diedhiou, Francis and Patte, Catherine and Steliarova-Foucher, Eva and Clavel, Jacqueline},
  title = {The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub‐Saharan Africa. A study from the Franco‐African Pediatric Oncology Group},
  journal = {Pediatric Blood & Cancer},
  year = {2023},
  volume = {70},
  number = {12},
  doi = {10.1002/pbc.30664}
}
Start for free →